Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

CVS Corp (CVS) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 87,426,680
  • Shares Outstanding, K 1,066,220
  • Annual Sales, $ 153,290 M
  • Annual Income, $ 5,237 M
  • 36-Month Beta 0.84
  • Price/Sales 0.51
  • Price/Book 2.43

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.46 +6.47%
on 12/30/16
84.72 -1.39%
on 01/18/17
+3.98 (+5.00%)
since 12/16/16
3-Month
69.30 +20.55%
on 11/08/16
88.58 -5.69%
on 10/24/16
-3.65 (-4.19%)
since 10/18/16
52-Week
69.30 +20.55%
on 11/08/16
106.67 -21.68%
on 05/09/16
-10.36 (-11.03%)
since 01/15/16

Most Recent Stories

More News
Target Slides 6% on Disappointing Holiday Sales

On Wednesday, shares of Target Corp. (TGT) are sliding, down around 6% in afternoon trading after the retailer reported disappointing sales during the recent holiday season.

Post Earnings Coverage as UnitedHealth Group Earnings Surged 56%

Upcoming AWS Coverage on CVS Health

Examining Volkswagen and Fiat Chrysler's Emissions Cheating Scandals

On today's episode of the Zacks Friday Finish Line podcast, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week's biggest story: the resolution of Volkswagen's emission cheating scandal...

Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks Bull and Bear of the Day

Fifth Street Asset Management, Cray, CVS Health, Mylan and Impax Laboratories highlighted as Zacks Bull and Bear of the Day

Stock Market Roundup, Jan. 12: AMZN Jobs, FCAU Cheating, AKS & X Tank

As investors continued to worry about President-elect Trump's targeting of the pharma industry, new concerns about U.S. industrial stocks help drag the markets down in morning trading Thursday. Nevertheless,...

CVS Debuts Cheap EpiPen Alternative

On Thursday, leading drug store chain CVS Health Corp. (CVS) announced that it is now selling a cheaper alternative to Mylan's (MYL) EpiPen.

CVS generic competitor to EpiPen, sold at a 6th the price

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of...

CVS Health Offers Patients Lowest Cash Price in the Market for Generic Epinephrine Auto-injector to Treat Allergic Reactions

CVS Health (NYSE: CVS) today announced that a low-cost epinephrine auto-injector option, the authorized generic for Adrenaclick® manufactured by Impax Laboratories (IPXL), is available at all CVS Pharmacy...

Is 2017 the Year of the Retail Famine?

It's just 10 days into the New Year, and some of the biggest retail brands in the country have announced major store closings due to dismal holiday season sales and the continued shift to online shopping....

Is 2017 the Year of the Retail Glut?

It???s not even 10 days into the New Year, and some of the biggest retail brands in the country have announced major store closings due to dismal holiday season sales and the continued shift to online...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed...

See More

Support & Resistance

2nd Resistance Point 85.34
1st Resistance Point 84.44
Last Price 83.54
1st Support Level 82.92
2nd Support Level 82.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.